NASDAQ:OGI Stock Quote
Organigram Holdings Inc. is a Canadian licensed producer of cannabis, focused on the development and cultivation of high-quality marijuana products for both medical and recreational markets
The company operates state-of-the-art facilities that utilize advanced technology and sustainable practices to grow and produce a variety of cannabis strains, including dried flower and cannabis oils. Organigram is committed to innovation in product development, creating a wide range of cannabis-infused products such as edibles, beverages, and vape oils. With a strong emphasis on compliance, quality control, and consumer education, Organigram aims to be a leading player in the evolving cannabis industry while promoting responsible use and supporting community initiatives.
Frequently Asked Questions
How does Organigram ensure product quality?
Organigram Holdings Inc. employs rigorous quality control measures throughout its cultivation and production processes. The company adheres to Good Manufacturing Practices (GMP) and conducts thorough testing in third-party labs to ensure that its products meet safety and potency standards.
How does Organigram handle regulatory compliance?
Organigram Holdings Inc. strictly adheres to regulations set forth by Health Canada and other governing bodies to maintain its licenses for cultivation and distribution. The company continuously monitors changes in legislation and ensures that its operations and products comply with all relevant regulations.
How does Organigram support community engagement?
Organigram Holdings Inc. is dedicated to community engagement and corporate social responsibility. The company actively participates in local initiatives, educational programs, and partnerships with community organizations to promote awareness about cannabis, health, and wellness.
Is Organigram Holdings Inc. publicly traded?
Yes, Organigram Holdings Inc. is publicly traded on the Nasdaq stock exchange under the ticker symbol OGI. It is also listed on the Toronto Stock Exchange (TSX) which allows investors to buy and sell shares of the company, reflecting its performance in the cannabis industry.
What are Organigram's financial performance indicators?
Organigram Holdings Inc.'s financial performance is typically assessed through various indicators such as revenue growth, profit margins, EBITDA, and cash flow. These metrics help investors and stakeholders evaluate the company's operational effectiveness and overall financial health within the competitive cannabis market.
What are Organigram's growth strategies?
Organigram Holdings Inc. employs a variety of growth strategies, including product innovation, expanding its market presence, and optimizing operational efficiencies. The company continuously invests in research and development to create new products and enhance its existing offerings to capture a larger market share.
What are the company's sustainability initiatives?
Organigram Holdings Inc. is committed to sustainability and minimizing its environmental impact. The company implements eco-friendly agricultural practices, energy-efficient production techniques, and aims to incorporate sustainable packaging solutions to reduce waste and promote environmental stewardship.
What challenges does Organigram face in the cannabis industry?
Like many companies in the cannabis industry, Organigram faces challenges such as regulatory changes, market competition, and pricing pressures. Additionally, the company must navigate evolving consumer preferences and public perceptions surrounding cannabis use in order to maintain its competitive edge and market share.
What distinguishes Organigram from its competitors?
Organigram differentiates itself from its competitors through its commitment to quality, innovation, and a diverse product lineup. The company leverages advanced cultivation techniques, invests in research and development, and cultivates strong brand recognition among consumers to set itself apart in the cannabis industry.
What does Organigram Holdings Inc. do?
Organigram Holdings Inc. is a Canadian licensed producer of cannabis products, focused on the research, cultivation, and production of high-quality medical and recreational cannabis. Through its various brands, including Edison Cannabis Co., Organigram aims to provide consumers with consistent and innovative products while adhering to strict regulatory standards.
What is the company's vision for the future?
Organigram Holdings Inc. envisions becoming a leading global cannabis company recognized for its quality products, innovation, and sustainable practices. The company aims to expand its market presence through strategic partnerships and product innovations as the cannabis industry continues to evolve.
What is the significance of the Executive Leadership Team at Organigram?
The Executive Leadership Team at Organigram plays a critical role in shaping the company's vision and strategic direction. Comprising experienced professionals from diverse backgrounds, this team is responsible for making key business decisions, driving growth initiatives, and fostering a culture of innovation within the organization.
What markets does Organigram Holdings Inc. operate in?
Organigram Holdings Inc. primarily operates in the Canadian cannabis market, which includes both medical and recreational segments. The company is also exploring international markets as regulations evolve, aiming to expand its reach and customer base beyond Canada.
What role does research and development play at Organigram?
Research and development (R&D) is a fundamental aspect of Organigram Holdings Inc.'s growth strategy. The company invests in R&D to develop new product formulations, improve cultivation techniques, and enhance overall quality, ensuring that it remains at the forefront of innovation in the cannabis industry.
What types of products does Organigram Holdings Inc. offer?
Organigram Holdings Inc. offers a diverse range of cannabis products, including dried flowers, oils, capsules, and pre-rolled joints. Furthermore, the company has introduced innovative products like edibles and vape pens, catering to a variety of consumer preferences and consumption methods.
When was Organigram Holdings Inc. founded?
Organigram Holdings Inc. was founded in 2013, during the early stages of the Canadian cannabis industry. Since then, it has grown significantly, navigating legislative changes and expanding its product offerings to meet the evolving needs of the cannabis consumer market.
Where is Organigram Holdings Inc. headquartered?
Organigram Holdings Inc. is headquartered in Moncton, New Brunswick, Canada. This location serves as the central hub for the company's operations, research, and development, enabling them to connect with consumers and the broader cannabis market.
Who are the key executives of Organigram Holdings Inc.?
Organigram Holdings Inc. is led by a dedicated team of executives, including its CEO, Beena Goldenberg, and CFO, Derek Watson. The team combines expertise in various fields, including agriculture, pharmaceuticals, and finance, to guide the company's strategy and growth in the cannabis market.
What is the current price of Organigram Global Inc. - Common Shares?
The current price of Organigram Global Inc. - Common Shares is 1.035
When was Organigram Global Inc. - Common Shares last traded?
The last trade of Organigram Global Inc. - Common Shares was at 1:38 pm EDT on April 2nd, 2025